Linda Penn (PhD) is a cancer research scientist who focuses her research on the molecular basis of cancer, and the development and application of novel anti-cancer therapeutics. She serves as Member at Large on the Board of Directors for the Canadian Cancer Society – Ontario Division and is also appointed as Canada Research Chair in Molecular Oncology. Linda is a scientific advisor on several national and international review panels, and is on several journal editorial boards.
Linda has recently been appointed as Director of UHN’s Office of Research Trainees (ORT). She is also a professor in the Medical Biophysics department at the University of Toronto and Senior Scientist at the Princess Margaret Cancer Centre (formerly the Ontario Cancer Institute).
Linda is a grateful recipient of CCS-funded research grants and has made regular presentations to the lay public on the latest developments in cancer research.
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.